Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation.
暂无分享,去创建一个
R. D. de Man | A. Osterhaus | J. Cornelissen | A. A. van der Eijk | S. Pas | J. Maaskant | H. Agteresch | M. Schipper | J. Versluis
[1] S. Görg,et al. Seroprevalence and incidence of hepatitis E virus infection in German blood donors , 2014, Transfusion.
[2] N. Schmitz,et al. Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany , 2012, Infection.
[3] S. Nick,et al. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States , 2012, Vox sanguinis.
[4] J. Izopet,et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[5] M. Koopmans,et al. Hepatitis E Virus Infection among Solid Organ Transplant Recipients, the Netherlands , 2012, Emerging infectious diseases.
[6] A. Ganser,et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low‐endemic country? , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[7] B. van der Holt,et al. Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients , 2011, Haematologica.
[8] J. Dumortier,et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. , 2011, Gastroenterology.
[9] R. Tedder,et al. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? , 2011, Vox sanguinis.
[10] L. Rostaing,et al. Hepatitis E Virus Infection without Reactivation in Solid-Organ Transplant Recipients, France , 2011, Emerging infectious diseases.
[11] L. Rostaing,et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. , 2010, Gastroenterology.
[12] O. Wichmann,et al. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review , 2009, Epidemiology and Infection.
[13] B. Dörken,et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation , 2009, Gut.
[14] H. Dalton,et al. Hepatitis E: an emerging infection in developed countries. , 2008, The Lancet. Infectious diseases.
[15] Jonathan K. Mitchell,et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease , 2008, European journal of gastroenterology & hepatology.
[16] Harry Vennema,et al. Chronic hepatitis E virus infection in liver transplant recipients , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] L. Rostaing,et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. , 2008, The New England journal of medicine.
[18] M. Bouwknegt,et al. Hepatitis E virus RNA in commercial porcine livers in The Netherlands. , 2007, Journal of food protection.
[19] H. Dalton,et al. The role of hepatitis E virus testing in drug‐induced liver injury , 2007, Alimentary pharmacology & therapeutics.
[20] B. van der Holt,et al. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation. , 2005, Experimental hematology.
[21] E. Wils,et al. Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement. , 2005, Blood reviews.
[22] F. Miedema,et al. Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. , 2003, Blood.
[23] K. Sullivan,et al. Infectious morbidity in long‐term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts , 1997, American journal of hematology.
[24] F. T. ten Kate,et al. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.